Healthcare
BioStem Technologies to Present at LD Micro Invitational, Highlighting Regenerative Medicine Advances
BioStem Technologies will present at the 16th Annual LD Micro Invitational, showcasing its proprietary allograft technologies and expanding presence in regenerative medicine.
NHS Rolls Out One-Minute Immunotherapy Injection for Cancer Patients
The NHS in England is offering thousands of cancer patients a one-minute injection of pembrolizumab instead of a lengthy infusion, significantly reducing administration time.
OS Therapies Gains Regulatory Clarity for OST-HER2 in Osteosarcoma, Stonegate Capital Reports
Stonegate Capital Partners updates coverage on OS Therapies, highlighting EMA rolling review and TGA endpoint alignment that shift OST-HER2 toward a global approval pathway, with key survival data catalysts in 2026.
AI Voice Analysis for Intoxication Detection Gains Traction: MindBio Therapeutics Featured in BioMedWire Editorial
MindBio Therapeutics Corp. is highlighted in a BioMedWire editorial for its AI-driven voice analysis platform that detects real-time impairment, with implications for law enforcement, workplace safety, and healthcare.
Oncotelic Therapeutics Highlighted in BioMedWire Editorial on CNS Drug Delivery Innovation
Oncotelic Therapeutics was featured in a BioMedWire editorial examining breakthroughs in central nervous system drug delivery, highlighting its proprietary intranasal nose-to-brain delivery platform that aims to overcome the blood-brain barrier for neurological diseases and biodefense applications.
Viemed Healthcare's Revenue Mix Shift Drives Strong Cash Flow Growth, Stonegate Says
Stonegate Capital Partners updates coverage on Viemed Healthcare, highlighting improved growth quality from diversification into sleep, resupply, and maternal health, which boosted free cash flow.
MindBio Therapeutics CEO Discusses AI Voice Detection Platform for Workplace Intoxication Screening on TechMediaWire Podcast
MindBio Therapeutics CEO Justin Hanka appeared on the TechMediaWire Podcast to detail the company's AI-driven voice analysis technology for detecting drug and alcohol intoxication, emphasizing its potential to improve safety in regulated workplaces like mining by enabling noninvasive, real-time screening.
HR.com Announces 2026 Employee Well-being Award Winners
HR.com has named Avidon Health and Hancock Health as winners of the 2026 Employee Well-being Awards, highlighting innovative approaches to workplace wellness that drive engagement and measurable business outcomes.
SureNano Science’s GLP-1 Triple Agonist GEP-44 Targets Obesity Market as Next-Generation Therapies Gain Traction
SureNano Science Ltd. is highlighted in a BioMedWire editorial for its subsidiary GlucaPharm’s GEP-44 triple agonist peptide, which aims to improve efficacy, tolerability, and delivery flexibility in the growing GLP-1 market for obesity and metabolic diseases.
Tonix Pharmaceuticals Reports Q1 2026 Results, Highlights TONMYA Commercial Growth and Pipeline Progress
Tonix Pharmaceuticals reported Q1 2026 financial results, showing early commercial success for its fibromyalgia drug TONMYA and advancing pipeline candidates including a Lyme disease prevention therapy.
Lantern Pharma to Report First Quarter 2026 Financial Results on May 15
Lantern Pharma announced it will release first-quarter 2026 financial results and operational updates on May 15, highlighting progress in its AI-driven precision oncology pipeline and the commercial launch of its withZeta.ai platform.
American Shared Hospital Services to Discuss Q1 2026 Financial Results on May 14
American Shared Hospital Services schedules a conference call for May 14 to review first quarter 2026 financial results, providing investors with insights into the company's performance and strategic direction.
FastBlast Offers Simple Nutrition Solutions for Spring and Summer Wellness
FastBlast highlights its plant-based, convenient nutrition products to help consumers maintain consistent healthy routines during seasonal transitions.
Auddia Highlights Influence Healthcare's AI-Powered Surgeon-Led Model Ahead of Merger Filing
Auddia Inc. showcases Influence Healthcare's AI-driven, surgeon-led value-based care platform as it prepares to file its S-4 merger registration, aiming to reduce administrative burden and lower costs in high-spend specialties.
ORGANA Essiac Tea Gains Traction on Amazon with Strong Customer Reviews
ORGANA International's Organa Genuine Essiac Tea is earning positive Amazon reviews for its traditional 4-herb formula and convenient liquid format, reflecting growing consumer interest in heritage-inspired wellness products.
Aclarion Adds First Private Practice Site in Los Angeles to CLARITY Trial
Aclarion announced the addition of Lanman Spinal Neurosurgery in Beverly Hills to its CLARITY trial, expanding enrollment beyond academic centers and highlighting growing interest in Nociscan for precise chronic low back pain diagnosis.
SS Innovations Achieves 4,500-Mile Telesurgery Milestone at Australian Surgeons Congress
SS Innovations successfully performed a live telesurgery spanning over 4,500 miles using its SSi Mantra robotic system, highlighting the potential to democratize global access to surgical expertise.
Study Suggests Earlier Immunotherapy Could Improve Survival in Late-Stage Solid Tumors
A systematic review in JAMA Network Open indicates that earlier administration of immune checkpoint inhibitor therapies may improve survival outcomes for patients with late-stage solid tumors, though further validation is needed.
SureNano Science Launches IND-Enabling Program for Obesity and Diabetes Drug GEP-44, Targeting a $200 Billion Market
SureNano Science has initiated an FDA-aligned GLP toxicology and pharmacology program for its lead candidate GEP-44, a multi-receptor peptide for obesity and type 2 diabetes, positioning the company to enter the rapidly growing GLP-1 market projected to reach $200 billion by 2030.
Oncotelic Therapeutics Advances Pipeline Without Dilution Through Partnership Strategy
Oncotelic Therapeutics is using a partnership-driven approach and its deep IP portfolio to advance its pipeline without shareholder dilution, as highlighted in a corporate update.
Wisconsin’s First Dedicated Emergency Mental Health Facility Opens in La Crosse
Emplify Health by Gundersen opens EmPATH, the state’s first emergency mental health facility, providing dedicated crisis care within 23 hours.
Choosing the Right Oral Rinse: Experts Stress Personalization Over One-Size-Fits-All
Oral care experts advise consumers to select therapeutic rinses based on individual health needs, highlighting the link between oral health and overall wellness.
MindBio Therapeutics Adds AI-Powered Fatigue Detection to Voice-Based Diagnostics Platform
MindBio Therapeutics expands its AI voice diagnostics platform with fatigue recognition technology for high-risk industries, with commercial testing expected in late Q2 2026.
HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch Aimed at Ischemia Detection
HeartBeam Inc. has initiated a pilot study for its investigational on-demand 12-lead ECG patch in coronary artery disease patients, potentially expanding ambulatory cardiac monitoring into ischemia detection within a $2 billion market.
NanoViricides Highlights Broad-Spectrum Antiviral Candidate After Andes Hantavirus Incident on Cruise Ship
NanoViricides points to its clinical-stage antiviral candidate NV-387 as a potential broad-spectrum therapeutic following an Andes hantavirus incident aboard a cruise ship, underscoring the need for versatile antiviral treatments.
Kairos Pharma Sets Virtual Annual Meeting, Discloses Going Concern Notice
Kairos Pharma announced its virtual annual meeting and disclosed a going concern notice in its 2025 annual report, highlighting financial uncertainties for the clinical-stage biopharmaceutical company.
Oncotelic Therapeutics Targets CNS Drug Delivery as Brain Therapeutics Innovation Accelerates
Oncotelic Therapeutics is leveraging its intranasal nose-to-brain delivery platform to address the challenge of delivering therapeutics across the blood-brain barrier, targeting Alzheimer's disease and biodefense applications in a rapidly evolving biopharma landscape.
MindBio Therapeutics Advances AI Voice-Based Intoxication Detection Amid Growing Real-Time Diagnostics Market
MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication in real time, targeting workplace safety, healthcare, and public safety markets as traditional testing methods face limitations.
SureNano Science Advances GEP-44 as Obesity Drug Market Poised to Exceed $200 Billion
SureNano Science Ltd., through its subsidiary GlucaPharm Inc., is developing GEP-44, a next-generation GLP-1 triple agonist peptide targeting obesity and metabolic disorders, as the global market for such therapies is projected to surpass $200 billion.
SureNano Science Advances Next-Generation GLP-1 Platform with Triple Agonist Peptide GEP-44
SureNano Science Ltd. is developing GEP-44, a novel triple agonist peptide for improved GLP-1 therapy, aiming to address obesity and diabetes alongside major players like Eli Lilly and Novo Nordisk.